FOMEPIZOLE AP-HP 5 mg/ml, concentrate for solution for infusion 5 ampoules of 20 ml
Active ingredients: Fomepizole, Fomepizole sulfate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Concentrate for solution for infusion5 ampoules of 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FOMEPIZOLE AP-HP 5 mg/mL, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 20 ml
- Marketing authorisation holder
- ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS - AP-HP
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Oct 1999
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63945150CIP75620233CIP133400956202331Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SULFATE DE FOMÉPIZOLEsolution | — | SA |
| FOMÉPIZOLEsolution | 5 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.